Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MOVING NOW! -- Ignore unavailable to you. Want to Upgrade?

To: nokomis who wrote (7388)	5/9/2002 11:52:36 AM
From: 2MAR$	Read Replies (2) \| Respond to of 8046

CHIR Chiron 10-Q discloses Nevada AG complaint (38.18 -0.90) In company's 10-Q report filed with the SEC yesterday, CHIR reports that in March the State of Nevada through its Attorney General filed a complaint in the Second Judicial District Court in Washoe County against 10 biotechnology and pharmaceutical companies, including Chiron, concerning setting average wholesale prices for various products, including DepoCyt, that are reimbursed by Medicare and Medicaid. The Attorney General alleges that Defendants violated Nevada state and common laws on unfair and deceptive trade practices and consumer protection, Medicaid fraud, racketeering, and seeks both compensatory and punitive damages.